Protecting university students in the UK against meningococcal disease: vaccination is the way forward

Ala’aldeen D Oldfield N Bidmos F . Carriage of meningococci by university students, United Kingdom. Emerging Infectious Diseases 2011; 17: 1762–3.

Visintin C Mugglestone M Fields E . Management of bacterial meningitis and meningococcal septicaemia in children and young people: summary of NICE guidance. British Medical Journal 2010; 340: c3209. doi: http://dx.doi.org/10.1136/bmj.c3209

Borg J Christie D Coen P . Outcomes of meningococcal disease in adolescence: prospective, matched-cohort study. Pediatrics 2009; 123: e502–9

Health Protection Agency. Invasive meningococcal infection (England and Wales), laboratory reports, weeks 40-53/2011. Health Protection Report Weekly Report 2012; 6: 3–4. Available online at http://www.hpa.org.uk/hpr/archives/2012/hpr0412.pdf (Last accessed 6 January 2013)

Halperin S Bettinger J Greenwood B . The changing and dynamic epidemiology of meningococcal disease. Vaccine 2012 30(Suppl 2): B26–36

Khatami A Peters A Robinson H . Maintenance of immune response throughout childhood following serogroup C meningococcal conjugate vaccination in early childhood. Clinical and Vaccine Immunology 2011; 18: 2038–42

Cooper B DeTora L Stoddard J . Menveo®: a novel quadrivalent meningococcal CRM197 conjugate vaccine against serogroups A, C, W-135 and Y. Expert Review of Vaccines 2011; 10: 21–33

Trotter C Findlow H Borrow R . Seroprevalence of serum bactericidal antibodies against group W135 and Y meningococci in England in 2009. Clinical and Vaccine Immunology 2012; 19: 219–22

Ladhani S Lucidarme J Newbold L . Invasive meningococcal capsular group Y disease, England and Wales, 2007–2009. Emerging Infectious Diseases 2012; 18: 63–70

Ladhani S Flood J Ramsay M . Invasive meningococcal disease in England and Wales: implications for the introduction of new vaccines. Vaccine 2012; 30: 3710–16

Salvadori M Bortolussi R Canadian Paediatric Society, Infectious Diseases and Immunization Committee. Meningococcal vaccines in Canada: an update. Paediatrics & Child Health 2011; 16: 485–6

Memish Z Al Rabeeah A . Health conditions for travellers to Saudi Arabia for the pilgrimage to Mecca (Hajj) 1432 (2011). Journal of Infection and Public Health 2011; 4: 105–7

Santolaya M O’Ryan M Valenzuela M . Immunogenicity and tolerability of a multicomponent meningococcal serogroup B (4CMenB) vaccine in healthy adolescents in Chile: a phase 2b/3 randomised, observer-blind, placebo-controlled study. Lancet 2012; 379: 617–24

Bai X Findlow J Borrow R . Recombinant protein meningococcal serogroup B vaccine combined with outer membrane vesicles. Expert Opinion on Biological Therapy 2011; 11: 969–85

Su E Snape M . A combination recombinant protein and outer membrane vesicle vaccine against serogroup B meningococcal disease. Expert Review of Vaccines 2011; 10: 575–88